Press release
Atrial Fibrillation - Pipeline Drugs and Companies Insight Report, 2023 Updates: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments
"Download PDF Sample Pages to Get an in-depth Assessment of the Emerging Therapies and Key -https://www.globalinsightservices.com/request-sample/GIS31160
Atrial fibrillation is a type of cardiac arrhythmia acclaimed by an anomalous cardiac rhythm element by a disturbance in heart's electrical system. There are three types of atrial fibrillation Paroxysmal atrial fibrillation, Persistent atrial fibrillation, Long-standing persistent atrial fibrillation.
Causes of atrial fibrillation are augmentation of blood clots within the upper chambers of the heart and age, heart disease, high blood pressure, family history and drinking alcohol.
Symptoms include decreased blood pressure, weakness, lightheadedness, confusion and chest pain.
Atrial fibrillation is diagnosed by electrocardiogram (ECG or EKG), blood tests, holter monitor, chest X-ray.
Atrial fibrillation is treated by lifestyle changes and drugs like potassium channel blockers, beta-blockers and calcium channel blockers.
Read more about Atrial Fibrillation - Drug Pipeline Landscape, 2023 Insight here:https://www.globalinsightservices.com/reports/atrial-fibrillation-drug-pipeline-landscape/
There are many clinical trials currently ongoing in atrial fibrillation drug development. Some of the most promising trials are studying new ways to prevent or treat atrial fibrillation, including new drugs, devices, and surgical procedures. Many of these trials are still in the early stages, but they offer hope for better treatments for this common and potentially deadly condition.
Major pharmaceutical companies are involved in the development of potential drug candidates to improve the treatment of Atrial Fibrillation treatment such as Xeomin, Abelacimab, HSY244, and others. Key players involved in the development of therapies to treat Atrial Fibrillation are AbbVie Inc, Bayer, Novartis, and others. Two drugs are under Phase III clinical trials and 10+ drugs are in Phase II clinical trials and some other drugs are under Phase I, preclinical and discovery stages of development.
Buy your copy now: https://www.globalinsightservices.com/checkout/single_user/GIS31160
Report Covers the Emerging Pipeline Products Under Different Phases of Clinical Development Like
- Late-stage products (Phase III)
- Mid-stage products (Phase II)
- Early-stage product (Phase I)
- Pre-clinical and Discovery stage candidates
- Discontinued & Inactive candidates
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Atrial Fibrillation - Pipeline Drugs and Companies Insight Report, 2023 Updates: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments here
News-ID: 2944177 • Views: 499
More Releases from Global Insight Services
Infection Control Market to grow further up to USD 42.6 billion by 2031 | STERIS …
New York, Global Infection Control Market was valued at USD 32.0 billion in 2021 and it is anticipated to grow further up to USD 42.6 billion by 2031, at a CAGR of 2.9% during the forecast period.
Global Infection Control Market report from Global Insight Services is the single authoritative source of intelligence on Infection Control Market. The report will provide you with analysis of impact of latest market disruptions such…
Intraoperative Imaging Market to grow further till USD 3.3 billion by 2031 | Gen …
New York, Global Intraoperative Imaging Market was valued at USD 1.9 billion in 2021 and it is anticipated to grow further till USD 3.3 billion by 2031, at a CAGR of 5.6% during the forecast period.
Global Intraoperative Imaging Market report from Global Insight Services is the single authoritative source of intelligence on Intraoperative Imaging Market. The report will provide you with analysis of impact of latest market disruptions such as…
Potassium Chloride Market Will Rise Due to Growing Demand for Potassium-based Fe …
New York, Global Potassium Chloride Market report from Global Insight Services is the single authoritative source of intelligence on Potassium Chloride Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories,…
Polymeric Sand Market Showing Impressive Growth during Forecast Period 2021 - 20 …
New York, Global Polymeric Sand Market report from Global Insight Services is the single authoritative source of intelligence on Polymeric Sand Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories,…
More Releases for Atrial
Atrial Fibrillation Stroke Treatment Market Segmentation By Atrial Fibrillation …
The arrhythmia problem occurs due to irregular heartbeats which can cause atrial fibrillation stoke. The irregular manner (increase pattern or lower pattern of heart beats) of heart beating pattern can cause atrial fibrillation stroke. The atrial fibrillation stroke causes major problem of heart and increase heart related problem. The patient which are suffering from atrial fibrillation effect two chamber of heart and atria present below the heart will lead to…
Atrial Fibrillation Market
Atrial Fibrillation Market is predicted to grow at a double digit CAGR over the forecast period (2017 to 2023). Atrial fibrillation, also denoted as AF, is an irregular or fast heart rhythm. It raises the dangers of chest pain, heart strokes, congestive heart failure, or cardiac discomfort. The typical indications of AF are dizziness, confusion, fainting, or tiredness.
Therapeutic advancements and the burgeoning aged populace also drive the industry. Supportive clinical…
Atrial Fibrillation Stroke Treatment Market Segmentation By Atrial Fibrillation …
The arrhythmia problem occurs due to irregular heartbeats which can cause atrial fibrillation stoke. The irregular manner (increase pattern or lower pattern of heart beats) of heart beating pattern can cause atrial fibrillation stroke. The atrial fibrillation stroke causes major problem of heart and increase heart related problem. The patient which are suffering from atrial fibrillation effect two chamber of heart and atria present below the heart will lead to…
Atrial Fibrillation Market Opportunity Analysis, 2018-2026
Atrial fibrillation, also known as A-fib or AF, is an irregular heartbeat exemplified by rapid and abnormal beating of the heart. Most episodes of atrial fibrillation have no symptoms or fewer symptoms such as intermittent heart palpitations, lightheadedness, fainting, chest pain, and shortness of breath. Atrial fibrillation is linked with an elevated risk of heart failure, stroke, and dementia. The disease is a kind of supraventricular tachycardia. Risk factors associated…
Atrial Septal Defect Market Future Opportunities2017 - 2025
Global Atrial Septal Defect Market: Outlook
Atrial septal defect is one of the most common congenital cardiac diseases and usually affects women more than men. It is characterized by a hole or defect in the interatrial septum that separates the heart’s two upper chambers, i.e., atria. The opening in the septum usually closes when the baby is born, but in few cases if the opening does not close, the hole…
Atrial Fibrillation Market Analysis, Forecast, and Assessment 2026
Increasing prevalence of common diseases and conditions such as obesity, diabetes, hypertension, etc., are leading to the risk of various heart problems. Moreover, the rise in people suffering from high blood pressure, and valvular heart disease due to the rheumatic fever are some of the most common risk factors for atrial fibrillation. Along with the increasing number of people suffering from atrial fibrillation, especially among the geriatric population. There has…
